I
I
III

I
I
H

UUID: CFF9837F- -C69E- 441D- BESF--1I.8A0663R67e355a
TCGA-YA-ABS7-01A- PR

II
I

I
I
IIIIII

IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
II IIIIIIIIIIIIIIIIIII||IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICIIEd

 

IIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIII . ZZZED 0’5
Wm), I NOS
Research Gross Description , 8/703

male with liver and adrenal masses 5.1111 ; (lg/W 9,23 1.)
Research Dx

Cy) I/ I 7/I 9‘
Liver, right hepatectomy:

Poorlytdifferentiated malignant neoplasm most consistent with hepatocellular carcinoma, see case
summary, see comment.

CASE SUMMARY FOR HEPATOCELLULAR CARCINOMA - RIGHT HEPATECTOMY:
Specimen: Liver, gallbladder, adrenal gland, periportal lymph node.
Procedure: Right hepatectomy, left hepatic core biopsy, cholecystectomy, adrenalectomy,
periportal lymph node excisional biopsy.
Tumor size: 12 cm (see gross description).
Tumor focality: Multiple (right lobe, left lobe).
Histologic type: Hepatocellular carcinoma, see comment.
Histologic grade: Grade 3 (poorly-differentiated).
Tumor extension: Tumor confined to liver.
Margins: Negative for tumor.
Parenchymal margin: Negative for tumor.
Distance of invasive carcinoma from closest margin: At least 1 cm from parenchymal
resection margin.
Lymphovascular invasion: Not identified.
Perineural invasion: Not identified.
Pathologic staging (pTNM):
Primary tumor (pT): pT3a (m) - Multiple tumors more than 5 cm.
Regional lymph nodes (pN): pNO - No regional lymph node metastasis.
Number lymph nodes examined: 1.
Number lymph nodes involved: 0.
Distant metastasis (pM): M (not applicable).
Additional pathologicfindings: Chronic hepatitis consistent with hepatitis C, inflammatory
activity grade 1 (portal chronic inflammation), ﬁbrosis stage 3 (septal fibrosis with
architectural distortion). Mild macrovesicular steatosis.

AJCC Staging (7th edition): pT3a(m) pNO M(not applicable)

Research QC
Tumor:

75% tumor nuclei
25% necrosis
0% normal

Normal:
100% liver

Research Specimen
T1-178 mg, T2- mg, T3- mg, T4- mg
N1-222 mg, N2- mg, N3- mg, N4- mg

Specimen Process Time
Plasma/serum/buffy coat

Cold ischemia start time:
Plasma frozen @

 

 

Serum frozen @ .-
Buffy coat frozen @

Tissue:

Cold ischemia start time:
Formalin ﬁxation start time,
Total cold ischemia time:
Formalin fixation stop time:
Total formalin ﬁxation time

Specimen Weight

Specimen Size
Plasma x 3

Serum x 3

Buffy coat x 1

Cryovials x 8
Normal x 4
Tumor x 4
Metastatic x 0

FFPE x 8
Normal x 4
Tumor x 4
Metastatic x 0

Study

Patient Consent
Yes

 

 

 

